CLEVER CULTURE SYSTEMS LIMITED - Announcements

2.86%

3.6¢

Market Cap $65.33M

Healthcare Biotechnology

Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based... Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based company that provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence (AI) and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology is a United States FDA-cleared AI technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is the exclusive distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe.More

Announcements

Filter Results

All Price Sensitive Only

CC5	Quarterly Investor Call		26/02/24	103.29KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/24	762.57KB	Share
CC5	Delivery Completes First Sale of APAS PharmaQC	PRICE SENSITIVE	22/02/24	116.03KB	Share
CC5	APAS PharmaQC Demonstrated at AstraZeneca UK Site		22/02/24	158.16KB	Share
CC5	Notification regarding unquoted securities - LBT		16/02/24	19.17KB	Share
CC5	Proposed issue of securities - LBT		12/02/24	16.43KB	Share
CC5	APAS PharmaQC BioPhorum Presentation to Industry Leaders		07/02/24	146.67KB	Share
CC5	Application for quotation of securities - LBT		05/02/24	18.05KB	Share
CC5	Company Presentation		05/02/24	1.3MB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	22/01/24	298.61KB	Share
CC5	Application for quotation of securities - LBT		17/01/24	27.54KB	Share
CC5	Notification of cessation of securities - LBT		10/01/24	21.7KB	Share
CC5	Change of Director's Interest Notice - B O'Dwyer		22/12/23	216.29KB	Share
CC5	Change of Director's Interest Notice - R Wilson		22/12/23	226.96KB	Share
CC5	Notice under Section 708A - Cleansing Notice		22/12/23	98.5KB	Share
CC5	Notice of initial substantial holder		22/12/23	649.34KB	Share
CC5	Change in substantial holding		19/12/23	306.76KB	Share
CC5	Change of Director's Interest Notice		19/12/23	243.13KB	Share
CC5	Initial Director's Interest Notice		19/12/23	193.14KB	Share
CC5	Application for quotation of securities - LBT		19/12/23	25.52KB	Share
CC5	Application for quotation of securities - LBT		19/12/23	24.95KB	Share
CC5	Application for quotation of securities - LBT		19/12/23	24.96KB	Share
CC5	Notification regarding unquoted securities - LBT		19/12/23	23.76KB	Share
CC5	Ceasing to be a substantial holder		15/12/23	296.23KB	Share
CC5	Director Appointment & Company Update		14/12/23	134.35KB	Share
CC5	Notice of change of interests of substantial holder		13/12/23	725.64KB	Share
CC5	Notice under Section 708A - Cleansing Notice		13/12/23	107.09KB	Share
CC5	Application for quotation of securities - LBT		11/12/23	27.54KB	Share
CC5	Application for quotation of securities - LBT		08/12/23	28.88KB	Share
CC5	Final Placement Concludes Entitlement Offer		08/12/23	150.88KB	Share
CC5	Final Director's Interest Notice		05/12/23	176.24KB	Share
CC5	APAS Presented at Australian Pharmaceutical Conference		30/11/23	115.07KB	Share
CC5	Results of Meeting		29/11/23	135.18KB	Share
CC5	CEO Presentation		29/11/23	1.04MB	Share
CC5	Chair's Address to Shareholders		29/11/23	129.57KB	Share
CC5	Board Changes and AGM Resolutions Update		27/11/23	114.63KB	Share
CC5	EU Market Development Initiated for APAS PharmaQC		23/11/23	242.77KB	Share
CC5	Notice under Section 708A - Cleansing Notice		21/11/23	106.73KB	Share
CC5	Notice of change of interests of substantial holder		21/11/23	307.24KB	Share
CC5	Notice of ceasing to be a substantial holder		21/11/23	33.12KB	Share
CC5	Notice of initial substantial holder		21/11/23	51.96KB	Share
CC5	Appendix 3Y - B Barnes		21/11/23	178.12KB	Share
CC5	Appendix 3Y - R Wilson		21/11/23	164.75KB	Share
CC5	Appendix 3Y - D Lismore		21/11/23	166.83KB	Share
CC5	Notice of initial substantial holder		20/11/23	1.56MB	Share
CC5	Notice of initial substantial holder		20/11/23	193.29KB	Share
CC5	Notice of initial substantial holder		20/11/23	164.04KB	Share
CC5	Application for quotation of securities - LBT		20/11/23	29.08KB	Share
CC5	Placement Completes Financial Restructure	PRICE SENSITIVE	20/11/23	132.13KB	Share
CC5	Top 20 Option Holders		15/11/23	130.11KB	Share
CC5	Application for quotation of securities - LBT		15/11/23	29.25KB	Share
CC5	Renounceable Rights Issue Results	PRICE SENSITIVE	15/11/23	119.95KB	Share
CC5	$1.7M SA Government Loan Restructure	PRICE SENSITIVE	06/11/23	148.64KB	Share
CC5	Entitlement Offer Underwriting Increased to $3.6M	PRICE SENSITIVE	27/10/23	81.08KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/23	385.09KB	Share
CC5	Proposed issue of securities - LBT		25/10/23	24.9KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		25/10/23	705.98KB	Share
CC5	Entitlement Offer Letters Mailed to Shareholders		23/10/23	457.81KB	Share
CC5	Investor Call - Entitlement Offer		13/10/23	108.43KB	Share
CC5	Proposed issue of securities - LBT		13/10/23	39.96KB	Share
CC5	Prospectus	PRICE SENSITIVE	13/10/23	788.16KB	Share
CC5	$4.5 million Entitlement Offer	PRICE SENSITIVE	13/10/23	148.04KB	Share
CC5	Full Repayment of $1.38M Share Placement Facility	PRICE SENSITIVE	13/10/23	114.6KB	Share
CC5	APAS PharmaQC Exhibited at Pharmaceutical Conference		05/10/23	243.03KB	Share
CC5	Annual Report		29/09/23	3.97MB	Share
CC5	Appendix 4G		29/09/23	286.43KB	Share
CC5	Corporate Governance Statement		29/09/23	265.65KB	Share
CC5	Application for quotation of securities - LBT		11/09/23	24.86KB	Share
CC5	LBT RECEIVES $848,673 R&D TAX INCENTIVE		05/09/23	96.07KB	Share
CC5	Notice under Section 708A - Cleansing Notice		04/09/23	86.02KB	Share
CC5	Application for quotation of securities - LBT		01/09/23	24.98KB	Share
CC5	Preliminary Annual Financial Report & Appendix 4E	PRICE SENSITIVE	31/08/23	899.3KB	Share
CC5	Proposed issue of securities - LBT		29/08/23	24.75KB	Share
CC5	Proposed issue of securities - LBT		29/08/23	25.01KB	Share
CC5	Application for quotation of securities - LBT		21/08/23	24.83KB	Share
CC5	First APAS PharmaQC Performance Data		10/08/23	470.64KB	Share
CC5	Notice under Section 708A - Cleansing Notice		07/08/23	86.24KB	Share
CC5	Non-Cash Impairment of Intangible Assets	PRICE SENSITIVE	04/08/23	116.2KB	Share
CC5	Application for quotation of securities - LBT		31/07/23	24.99KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/07/23	351.93KB	Share
CC5	Notification of cessation of securities - LBT		12/07/23	21.7KB	Share
CC5	Notification of cessation of securities - LBT		10/07/23	21.78KB	Share
CC5	Final Directors Interest Notice		05/07/23	184.05KB	Share
CC5	Initial Directors Interest Notice		05/07/23	138.93KB	Share
CC5	Proposed issue of securities - LBT		05/07/23	26.63KB	Share
CC5	Chairman Appointment/Resignation		03/07/23	118.7KB	Share
CC5	APAS Presented at ASM Conference		20/06/23	131.44KB	Share
CC5	APAS Compact Extension to Project Funding Timeframe		20/06/23	116.59KB	Share
CC5	Notice under Section 708A - Cleansing Notice		02/06/23	86.08KB	Share
CC5	Application for quotation of securities - LBT		02/06/23	24.98KB	Share
CC5	Notice under Section 708A - Cleansing Notice		26/05/23	86.34KB	Share
CC5	Application for quotation of securities - LBT		26/05/23	24.96KB	Share
CC5	New Company Presentation		12/05/23	1.59MB	Share
CC5	Upcoming Investor Webinar Presentation		10/05/23	102.78KB	Share
CC5	LBT Board - Chair Transition Process		08/05/23	107.09KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	365.77KB	Share
CC5	NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE		19/04/23	243.91KB	Share
CC5	Notification of cessation of securities - LBT		11/04/23	21.69KB	Share
CC5	Director Retirement & Appendix 3Z		30/03/23	253.29KB	Share
CC5	Notice under Section 708A - Cleansing Notice		23/03/23	86.52KB	Share

CC5 Quarterly Investor Call
26/02/24		103.29KB	Share
CC5 Half Yearly Report and Accounts
23/02/24	PRICE SENSITIVE	762.57KB	Share
CC5 Delivery Completes First Sale of APAS PharmaQC
22/02/24	PRICE SENSITIVE	116.03KB	Share
CC5 APAS PharmaQC Demonstrated at AstraZeneca UK Site
22/02/24		158.16KB	Share
CC5 Notification regarding unquoted securities - LBT
16/02/24		19.17KB	Share
CC5 Proposed issue of securities - LBT
12/02/24		16.43KB	Share
CC5 APAS PharmaQC BioPhorum Presentation to Industry Leaders
07/02/24		146.67KB	Share
CC5 Application for quotation of securities - LBT
05/02/24		18.05KB	Share
CC5 Company Presentation
05/02/24		1.3MB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
22/01/24	PRICE SENSITIVE	298.61KB	Share
CC5 Application for quotation of securities - LBT
17/01/24		27.54KB	Share
CC5 Notification of cessation of securities - LBT
10/01/24		21.7KB	Share
CC5 Change of Director's Interest Notice - B O'Dwyer
22/12/23		216.29KB	Share
CC5 Change of Director's Interest Notice - R Wilson
22/12/23		226.96KB	Share
CC5 Notice under Section 708A - Cleansing Notice
22/12/23		98.5KB	Share
CC5 Notice of initial substantial holder
22/12/23		649.34KB	Share
CC5 Change in substantial holding
19/12/23		306.76KB	Share
CC5 Change of Director's Interest Notice
19/12/23		243.13KB	Share
CC5 Initial Director's Interest Notice
19/12/23		193.14KB	Share
CC5 Application for quotation of securities - LBT
19/12/23		25.52KB	Share
CC5 Application for quotation of securities - LBT
19/12/23		24.95KB	Share
CC5 Application for quotation of securities - LBT
19/12/23		24.96KB	Share
CC5 Notification regarding unquoted securities - LBT
19/12/23		23.76KB	Share
CC5 Ceasing to be a substantial holder
15/12/23		296.23KB	Share
CC5 Director Appointment & Company Update
14/12/23		134.35KB	Share
CC5 Notice of change of interests of substantial holder
13/12/23		725.64KB	Share
CC5 Notice under Section 708A - Cleansing Notice
13/12/23		107.09KB	Share
CC5 Application for quotation of securities - LBT
11/12/23		27.54KB	Share
CC5 Application for quotation of securities - LBT
08/12/23		28.88KB	Share
CC5 Final Placement Concludes Entitlement Offer
08/12/23		150.88KB	Share
CC5 Final Director's Interest Notice
05/12/23		176.24KB	Share
CC5 APAS Presented at Australian Pharmaceutical Conference
30/11/23		115.07KB	Share
CC5 Results of Meeting
29/11/23		135.18KB	Share
CC5 CEO Presentation
29/11/23		1.04MB	Share
CC5 Chair's Address to Shareholders
29/11/23		129.57KB	Share
CC5 Board Changes and AGM Resolutions Update
27/11/23		114.63KB	Share
CC5 EU Market Development Initiated for APAS PharmaQC
23/11/23		242.77KB	Share
CC5 Notice under Section 708A - Cleansing Notice
21/11/23		106.73KB	Share
CC5 Notice of change of interests of substantial holder
21/11/23		307.24KB	Share
CC5 Notice of ceasing to be a substantial holder
21/11/23		33.12KB	Share
CC5 Notice of initial substantial holder
21/11/23		51.96KB	Share
CC5 Appendix 3Y - B Barnes
21/11/23		178.12KB	Share
CC5 Appendix 3Y - R Wilson
21/11/23		164.75KB	Share
CC5 Appendix 3Y - D Lismore
21/11/23		166.83KB	Share
CC5 Notice of initial substantial holder
20/11/23		1.56MB	Share
CC5 Notice of initial substantial holder
20/11/23		193.29KB	Share
CC5 Notice of initial substantial holder
20/11/23		164.04KB	Share
CC5 Application for quotation of securities - LBT
20/11/23		29.08KB	Share
CC5 Placement Completes Financial Restructure
20/11/23	PRICE SENSITIVE	132.13KB	Share
CC5 Top 20 Option Holders
15/11/23		130.11KB	Share
CC5 Application for quotation of securities - LBT
15/11/23		29.25KB	Share
CC5 Renounceable Rights Issue Results
15/11/23	PRICE SENSITIVE	119.95KB	Share
CC5 $1.7M SA Government Loan Restructure
06/11/23	PRICE SENSITIVE	148.64KB	Share
CC5 Entitlement Offer Underwriting Increased to $3.6M
27/10/23	PRICE SENSITIVE	81.08KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
26/10/23	PRICE SENSITIVE	385.09KB	Share
CC5 Proposed issue of securities - LBT
25/10/23		24.9KB	Share
CC5 Notice of Annual General Meeting/Proxy Form
25/10/23		705.98KB	Share
CC5 Entitlement Offer Letters Mailed to Shareholders
23/10/23		457.81KB	Share
CC5 Investor Call - Entitlement Offer
13/10/23		108.43KB	Share
CC5 Proposed issue of securities - LBT
13/10/23		39.96KB	Share
CC5 Prospectus
13/10/23	PRICE SENSITIVE	788.16KB	Share
CC5 $4.5 million Entitlement Offer
13/10/23	PRICE SENSITIVE	148.04KB	Share
CC5 Full Repayment of $1.38M Share Placement Facility
13/10/23	PRICE SENSITIVE	114.6KB	Share
CC5 APAS PharmaQC Exhibited at Pharmaceutical Conference
05/10/23		243.03KB	Share
CC5 Annual Report
29/09/23		3.97MB	Share
CC5 Appendix 4G
29/09/23		286.43KB	Share
CC5 Corporate Governance Statement
29/09/23		265.65KB	Share
CC5 Application for quotation of securities - LBT
11/09/23		24.86KB	Share
CC5 LBT RECEIVES $848,673 R&D TAX INCENTIVE
05/09/23		96.07KB	Share
CC5 Notice under Section 708A - Cleansing Notice
04/09/23		86.02KB	Share
CC5 Application for quotation of securities - LBT
01/09/23		24.98KB	Share
CC5 Preliminary Annual Financial Report & Appendix 4E
31/08/23	PRICE SENSITIVE	899.3KB	Share
CC5 Proposed issue of securities - LBT
29/08/23		24.75KB	Share
CC5 Proposed issue of securities - LBT
29/08/23		25.01KB	Share
CC5 Application for quotation of securities - LBT
21/08/23		24.83KB	Share
CC5 First APAS PharmaQC Performance Data
10/08/23		470.64KB	Share
CC5 Notice under Section 708A - Cleansing Notice
07/08/23		86.24KB	Share
CC5 Non-Cash Impairment of Intangible Assets
04/08/23	PRICE SENSITIVE	116.2KB	Share
CC5 Application for quotation of securities - LBT
31/07/23		24.99KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
26/07/23	PRICE SENSITIVE	351.93KB	Share
CC5 Notification of cessation of securities - LBT
12/07/23		21.7KB	Share
CC5 Notification of cessation of securities - LBT
10/07/23		21.78KB	Share
CC5 Final Directors Interest Notice
05/07/23		184.05KB	Share
CC5 Initial Directors Interest Notice
05/07/23		138.93KB	Share
CC5 Proposed issue of securities - LBT
05/07/23		26.63KB	Share
CC5 Chairman Appointment/Resignation
03/07/23		118.7KB	Share
CC5 APAS Presented at ASM Conference
20/06/23		131.44KB	Share
CC5 APAS Compact Extension to Project Funding Timeframe
20/06/23		116.59KB	Share
CC5 Notice under Section 708A - Cleansing Notice
02/06/23		86.08KB	Share
CC5 Application for quotation of securities - LBT
02/06/23		24.98KB	Share
CC5 Notice under Section 708A - Cleansing Notice
26/05/23		86.34KB	Share
CC5 Application for quotation of securities - LBT
26/05/23		24.96KB	Share
CC5 New Company Presentation
12/05/23		1.59MB	Share
CC5 Upcoming Investor Webinar Presentation
10/05/23		102.78KB	Share
CC5 LBT Board - Chair Transition Process
08/05/23		107.09KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	365.77KB	Share
CC5 NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE
19/04/23		243.91KB	Share
CC5 Notification of cessation of securities - LBT
11/04/23		21.69KB	Share
CC5 Director Retirement & Appendix 3Z
30/03/23		253.29KB	Share
CC5 Notice under Section 708A - Cleansing Notice
23/03/23		86.52KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.6¢		Change 0.001(2.86%)		Mkt cap ! $65.33M

Open	High	Low	Value	Volume
3.5¢	3.6¢	3.5¢	$18.02K	513.3K

Buyers (Bids)

No.	Vol.	Price($)
7	991682	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	1072927	5

View Market Depth

No.	Vol.	Price($)
7	991682	0.034
6	971865	0.033
4	504275	0.032
1	32258	0.031
4	618150	0.030

Price($)	Vol.	No.
0.036	1072927	5
0.037	1353817	1
0.039	1128436	4
0.040	3000000	2
0.041	300000	1

Last trade - 15.55pm 21/08/2025 (20 minute delay)


Last 3.6¢		Change 0.001 ( 2.86 %)
Open	High	Low	Volume
3.5¢	3.6¢	3.5¢	84104
Last updated 15.55pm 21/08/2025 ?

CC5 (ASX) Chart

CLEVER CULTURE SYSTEMS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories